| 摘要 |
The present invention provides an amorphous form of afatinib dimaleate, processes for its preparation, a pharmaceutical composition comprising it, and its use for the treatment of metastatic non-small cell lung cancer. The present invention provides an amorphous form of afatinib dimaleate, processes for its preparation, a pharmaceutical composition comprising it, and its use for the treatment of metastatic non-small cell lung cancer. The amorphous form of afatinib dimaleate Is a highly pure, easy to filter, free-flowing solid, and is stable towards polymorphic conversion. |
